Want to join the conversation?
$ONCE and $PFE said FDA granted breakthrough therapy designation to SPK-9001, which is being investigated in ongoing Phase 1/2 trial as potential one-time therapy, to treat rare genetic bleeding disorder hemophilia B. The designation is intended to expedite development and FDA review of drugs to treat serious or life-threatening disease.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?